Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids
Patents for C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
08/2005
08/16/2005US6930211 Production methods of citalopram and intermediates therefor
08/16/2005US6930198 Method for production of unsaturated carboxylic ester
08/16/2005US6930195 from the reaction product of cyclic carbonates, hydroxy alkyl carbonates and alcohols
08/16/2005CA2309449C Esters with musky odor and their use in perfumery
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/16/2005CA2125075C Process for the preparation of propylene glycol carbonate
08/11/2005WO2005056510A3 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
08/11/2005WO2005051372A3 Method of purifying pravastatin
08/11/2005WO2005025492A3 Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease
08/11/2005US20050176987 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof
08/11/2005US20050176979 Manufacturing process for the preparation of a, a-branched alkane carboxylic acids providing esters with an improved softness
08/11/2005US20050176917 organotin or organotitanium transesterification catalysts in two step heating of a hydroxyalkyl-terminated polyester oligomer of intermediate weight to produce a higher molecular weight macrocyclic polyester
08/11/2005US20050176824 Novel substance having antitumor/anti-inflammatory activity
08/11/2005US20050176808 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
08/11/2005US20050176797 Thromboembolic disorders; e.g. 2-[5-(5-carbamimidoyl-1H-benzoimidazol-2-yl)-5'-fluoro-6,2'-dihydroxy-biphenyl-3-yl]-succinic acid
08/11/2005US20050176778 Isoprenyl derivatives and their use in the title treatment and prevention of osteoporosis and cardiovascular calcification
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176689 For therapy, useful as regulators of cell proliferation and differentiation, and particularly as agents for treating skin-related diseases
08/11/2005US20050175910 Imaging member
08/11/2005US20050175555 2,4,6,8,10,12,14-hexadecaheptaenol in cyclodextrins; antitumor , antiinflammatory, antiaging, antiprolifrative agent, antioxident; activation of free radical production, cardiovascular disorders, atherosclerosis; cosmetic and pharmaceutical use
08/11/2005DE60104684T2 Herstellung von tertiär-butylessigsäureester aus mtbe Preparation of tert-butylessigsäureester from mtbe
08/10/2005EP1561748A1 Malonic acid monoesters and process for producing the same
08/10/2005EP1561743A1 Compound protecting against ultraviolet
08/10/2005EP1177273B8 Highly concentrated free-flowing pearly lustre concentrates
08/10/2005CN1653806A High-resolution image projection
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1653029A High-purity (fluoroalkyl)benzene derivative and process for producing the same
08/10/2005CN1653023A Method for producing C13-alcohol mixtures
08/10/2005CN1651398A Production technology of extracting chlorogenic acid from burdock leaf
08/10/2005CN1651397A Menthol derivative containing fatty acid and preparation containing said derivative
08/10/2005CN1651396A Method of separating alpha ethyl linolenate by cuprous chloride complexation adsorption
08/10/2005CN1651395A Borneol fatly acid ester derivative and preparation containing said derivative
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214035C Surface-active photoinitiators
08/10/2005CN1214021C Process for producing isocoumarins and intermediates for same
08/10/2005CN1213998C Processes and intermediates useful to make antifolates
08/10/2005CN1213992C Preparation of 4-methyl-2,3,5,6-tetrafluorobenzyl alcohol
08/10/2005CN1213989C New polymerisable liquid crystalline compounds
08/10/2005CN1213988C Process for preparing 3,7-dimethyl-1,6-octadiene-3-yl3-(beta-naphthyl)-3-oxo-propionate
08/10/2005CN1213986C Catalyst composition and method for producing diaryl carbonates
08/10/2005CN1213985C Process for production of t-butyl acetate from MTBE
08/10/2005CN1213983C Sulfur containing promoter for alkanes oxidative dehydrogenation processes
08/10/2005CN1213807C Hydroformylation of unsaturated compounds using polymeric phosphite ligands
08/09/2005US6927302 Process for the arylation of olefins
08/09/2005US6927299 Comprises reaction of fatty acid and glycidol in presence of phosphoric acid-based acidic catalyst
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors
08/09/2005CA2164690C Method for safening herbicides in cereal crops using 5-aryloxy-1, 2-(disubstituted)benzene compounds
08/04/2005WO2005070913A1 Thermally modulated antioxidants
08/04/2005WO2005070866A2 Polymer dispersions or solutions comprising 3,4 dihydroxyphenyl groups
08/04/2005WO2005070865A1 Method of preparing monoesters of polyhydroxyl alcohols
08/04/2005WO2005070856A1 Octahydronaphthalene derivative and medicine
08/04/2005WO2005070855A1 Integrated process for acetic acid and methanol
08/04/2005WO2005069998A2 Novel sirtuin activating compounds and methods for making the same
08/04/2005US20050171382 Contacting crude (meth)acrylic acid containing transition metal components as impurities with a cation exchange resin to remove the transition metal component,water being added to contacting the crude (meth)acrylic acid with the cation exchange resin, wherein the transition metal component is manganese
08/04/2005US20050171379 Separation of diastereoisomers
08/04/2005US20050171375 Reacting an alkene and an alcohol with an acid halide; high conversion and high yield without using an alcohol as the raw material; useful as polymerizable monomer for photoresist of vacuum ultraviolet region
08/04/2005US20050171204 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance
08/04/2005US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050170169 Composite and method of manufacturing the same
08/04/2005US20050170027 Oleic acid ester derivative; avocado extract in n-hexane solvent
08/04/2005US20050167362 Process for recovering liquid chemical products in chemical production facility
08/04/2005CA2554619A1 Method of preparing monoesters of polyhydroxyl alcohols
08/04/2005CA2554186A1 Process for the reactive extraction of levulinic acid
08/04/2005CA2554119A1 Thermally modulated antioxidants
08/04/2005CA2553248A1 Treatment of cancer using benzoic acid derivatives
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558572A2 Novel compounds and their use as prar-modulators
08/03/2005EP1558230A1 Spirocyclopropyl amides and acids and their therapeutic applications
08/03/2005EP1499625B1 Ferrocenyl ligands and method for the production of such ligands
08/03/2005EP1305284A4 Process and intermediate compounds for the preparation of pyrrolidines
08/03/2005CN1650237A Charge controllers
08/03/2005CN1649905A Incorporable photoinitiator
08/03/2005CN1649872A Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines
08/03/2005CN1649823A Alkyne compounds
08/03/2005CN1649822A Intergrated chemical processes for industrial utilization of seed oils
08/03/2005CN1648119A Several new pyrethroid compounds
08/03/2005CN1648118A Gas phase chlorination method and device for preparing chloro-formic acid-1-chloro-formic ester
08/03/2005CN1648117A Process for producing dialkyl itaconate
08/03/2005CN1213032C Imidazolidine-based metal carbene metathesis catalysts
08/03/2005CN1213018C Liquid crystal compounds
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/03/2005CN1213016C Split method for preparing intermediate enriched with antimer
08/02/2005US6924753 Robust system for transmitting and receiving map data
08/02/2005US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924262 Use of unsaturated esters as perfuming ingredients
08/02/2005US6924082 Optically and/or thermally switchable; conjugation on-state and conjugation off-state of the heptalene core pi -electrons with the substituent pi-electrons advantageously take place with the lowest activation energy and only low energy
08/02/2005CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses
07/28/2005WO2005042462A3 Process for preparing functional group-containing olefinic compounds
07/28/2005US20050165923 Transmitter device and relay device for performing data transmission control
07/28/2005US20050165208 free-radical crosslinkers for polymers (superabsorbents); high hydrolysis stability; Acrylic Ester
07/28/2005US20050165118 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
07/28/2005US20050165117 Hyperforin derivatives, the use thereof and formulations containing them
07/28/2005US20050165101 delivers essential or beneficial fatty acids in an optimal manner with respect to stability and biosorptivity
07/28/2005US20050165100 Conjugated fatty acid esters
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 548